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The search for new and effective antimicrobial 
and antifungal agents is an important task of medical 
chemistry. In this paper is set out the results of 
microbiological screening of new derivatives of 
[1,2,4]triazolo[4,3-a]pyrazine. Investigations have shown 
that these compounds show moderate antimicrobial 
activity against standard test systems, and some of them 
can be used for further modification in order to enhance 
their influence on the microbial cell. 
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The massive and uncontrolled use of 
antimicrobial and antifungal agents leads to appear  
microbial resistance to popular drugs [1-3] and in turn it 
limit the antibiotic use, which is one of the important 
causes of treatment failure [4]. In the latest report by the 
World Health Organization (WHO) [5], the problem of 
resistance to antimicrobial agents, including antibiotics, is 
considered globally. This means that the threat is not just 
a prediction for the future, but it’s the real situation in 
many countries today. The main solution to this problem 
is prevention of bacterial infection (personal hygiene, 
access to clean drinking water, etc.) in order to reduce the 
need for antibiotics and the search for new effective drugs 
with a new formula for the treatment of infectious 
diseases. 
From the literature it is known that derivatives of 
[1,2,4]triazolo[4,3-a]pyrazine testify have a wide range of 
biological actions [6-12]. Our attention was attracted by 
works, which had studied the antimicrobial activity some 
of compounds from this row [12] and their antifungal 
action [7]. 
 
Materials and methods 
We made a library of these compounds for 
virtual screening using the PASS C&T (Prediction 
Activity Spectra for Substances: Complex & Training) 
program [13-20] lean on the published data of the 
fragment of structures [1,2,4]triazolo[4,3-a]pyrazine 
activity. According to the results we have chosen 
[1,2,4]triazolo[4,3-a]pyrazin-8(7H)-one derivatives as the 
researching objects that had the most likelihood of 
manifestation of these pharmacological effects (Pa)  is 
within 0.5≤Ра≤0.8. These substances were synthesized by 
the authors according to the previously developed scheme 
at the National University of Pharmacy [21]. 
As a result, we have received 35 synthetic 













































Figure 2. The structural formula of the compounds of series 4, 5 and 6 
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Figure 3. The structural formula of the compounds of series 7 
 
Table 1. Objects of research 
Number R1 R2 X 
1{1} 4-FPh H - 
1{2} 4-ClPhCH2 Me - 
1{3} 4-OMePh Et - 
1{4} Ph Pr - 
1{5} 4-ClPhCH2 i-Pr - 
2{1} 3,4-diMePh (CH2)2COOH - 
2{2} 4-OMePh (CH2)2COOH - 
2{3} 4-ClPh (CH2)3COOH - 
2{4} 3-FPh (CH2)3COOH - 
2{5} 4-OMePh CH2CH(CH3)CH2COOH - 
3{1} Ph 4-ClPh - 
3{2} 4-OMePh 3,4-diOMePh - 
3{3} 4-FPh 4-ClPh - 
3{4} 4-FPh 3,4-diOEtPh - 
3{5} 4-MePhCH2 3,4-diOMePh - 
4{1} 4-iPrPh - S 
4{2} 4-BrPh - S 
4{3} 4-FPh - S 
4{4} 3-Cl-2-MePh - S 
4{5} 4-ClPhCH2 - S 
5{1} 2-OMePh - O 
5{2} 4-OEtPh - O 
5{3} 4-BrPh - O 
5{4} 3,4-diFPh - O 
3{5} 3-Cl-4-OMePh - O 
6{1} Ph 4-MePhCH2 O 
6{2} Ph 4-ClPhCH2 O 
6{3} 4-OMePh 4-ClPhCH2 O 
6{4} 4-FPh 4-MePhCH2 O 
6{5} 4-OMePh 4-ClPhNHCOCH2 O 
7{1} Ph 4-ClPhCH2 - 
7{2} 4-OMePh 4-MePhCH2 - 
7{3} 4-FPh 4-MePhCH2 - 
7{4} Ph 2-CF3PhNHCOCH2 - 
7{5} 4-BrPh 4-OMePhNHCOCH2 - 
* Me – methyl, Et – ethyl, Pr – propyl, Ph – phenyl. 
The research of antimicrobial and fungicidal 
activity of the synthesized compounds was carried out in 
the laboratory of antimicrobial agents State Institution «I. 
Mechnikov Institute of Microbiology and Immunology 
National Academy of Medical Sciences of Ukraine» 
under the leadership of  PhD, senior scientist 
V.V.Kazmirchuka. 
The activity of the synthesized compounds were 
studied by conventional method of the two-fold serial 
dilutions in liquid and solid nutrient medium [22-23]. For 
primary screening we have used a set of clinical and 
reference strains of microorganism: Escherichia coli 
ATCC 25922 (F-50), Staphylococcus aureus ATCC 
25923 (F-49), Bacillus anthracoides ATCC 1312, 
Pseudomonas aeruginosa ATCC 27853, Candida 
albicans ATCC 885-653, as bacterial cultures, 
recommended by the State Pharmacopoeia of Ukraine to 
determine antimicrobial drugs [24]. As the reference 
preparations were chosen pipemidic acid (Palin, «Lek» 
Pharmaceutical Company d.d., Slovenia) - modern 
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antimicrobial agent of class of fluoroquinolones, nalidixic 
acid (Nevigramon, «CHINOIN», Pharmaceutical and 
Chemical Works Co.Ltd., Hungary) - nalidixic acid 
derivative and fluconazole (Fluconazole, Open FC 
«Zdorovye», Ukraine) - modern antifungal agent. 
Conversion of IBC was held on the content of the active 
substance. 
The sensitivity of bacteria to the synthesized 
compounds were determined in Hottinger’s meat infusion 
broth (135 mg% amine nitrogen, рН 7,2-7,4). For 
cultivation of fungi of the genus Candida was used 
Sabouraud medium. 
Activity of substances determined by the 
minimum bacteriostatic (MBstK) and minimal bactericidal 
(MBcK) concentrations. The minimum bacteriostatic 
concentration (MBstK) was determined by the absence of 
visible growth of microorganisms in a liquid nutrient 
medium. The medium remained transparent in those tubes 
where the concentration of the substance was sufficient 
for complete inhibition of growth of the test 
microorganism. The minimum bactericidal concentration 
(MBcK) was determined by the absence of growth 
colonies after seeding of microorganisms from tubes on 
solid culture medium. 
All experiments were accompanied by 
appropriate controls (of the environmental control, 
bacterial cultures) and repeated three times. For the 
statistical data was used standard statistical software 
package Statistica 6.0 [25-29]. 
 
Results and Discussion 
As a result of microbiological screening were 
identified that antimicrobial and antifungal activity of 
some compounds of series [1,2,4]triazolo[4,3-a]pyrazin-
8-ones are equal or higher than the reference preparation 
(Table 2, 3).  
 









MBstK MBcK MBstK MBcK MBstK MBcK 
Palinum 6.25  25.0  12.5  
Nevigramon 50.0  50.0  50.0  
Fluconazolum       
1{1} 50.0 100.0 50.0 100.0 100.0 200.0 
1{2} 25.0 100.0 50.0 200.0 50.0 100.0 
1{3} 100.0 200.0 50.0 100.0 50.0 200.0 
1{4} 50.0 100.0 100.0 200.0 100.0 200.0 
1{5} 50.0 100.0 50.0 100.0 50.0 100.0 
2{1} 50.0 100.0 50.0 100.0 100.0 200.0 
2{2} 50.0 200.0 25.0 50.0 100.0 200.0 
2{3} 25.0 50.0 50.0 100.0 50.0 100.0 
2{4} 50.0 100.0 25.0 100.0 25.0 50.0 
2{5} 50.0 100.0 50.0 200.0 100.0 200.0 
3{1} 50.0 100.0 25.0 50.0 25.0 100.0 
3{2} 100.0 200.0 100.0 200.0 50.0 100.0 
3{3} 50.0 100.0 50.0 100.0 25.0 50.0 
3{4} 50.0 100.0 50.0 100.0 25.0 50.0 
3{5} 100.0 200.0 50.0 200.0 50.0 100.0 
4{1} 50.0 100.0 50.0 100.0 50.0 100.0 
4{2} 25.0 50.0 50.0 100.0 12.5 25.0 
4{3} 25.0 50.0 50.0 100.0 25.0 50.0 
4{4} 25.0 50.0 25.0 50.0 12.5 25.0 
4{5} 25.0 100.0 50.0 100.0 50.0 100.0 
3{1} 100.0 200.0 50.0 100.0 100.0 200.0 
5{2} 50.0 100.0 50.0 100.0 100.0 200.0 
5{3} 25.0 100.0 25.0 50.0 50.0 100.0 
5{4} 50.0 100.0 25.0 50.0 50.0 100.0 
5{5} 25.0 100.0 25.0 50.0 25.0 50.0 
6{1} 100.0 200.0 50.0 200.0 50.0 100.0 
6{2} 50.0 100.0 25.0 50.0 50.0 100.0 
6{3} 50.0 100.0 50.0 200.0 100.0 200.0 
6{4} 25.0 50.0 50.0 100.0 50.0 100.0 
6{5} 25.0 50.0 12.5 25.0 50.0 100.0 
7{1} 25.0 50.0 50.0 100.0 50.0 100.0 
7{2} 50.0 100.0 100.0 200.0 50.0 100.0 
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7{3} 25.0 50.0 50.0 100.0 50.0 100.0 
7{4} 12.5 50.0 25.0 50.0 50.0 100.0 
7{5} 12.5 25.0 25.0 50.0 12.5 25.0 
 









MBstK MBcK MBstK MBcK MFstK MFcK 
Palinum 12.5  12.5  12.5  
Nevigramon   6.25    
Fluconazolum     50.0  
1{1} 50.0 200.0 100.0 200.0 25.0 50.0 
1{2} 25.0 50.0 100.0 200.0 25.0 100.0 
1{3} 50.0 100.0 100.0 200.0 50.0 100.0 
1{4} 100.0 200.0 50.0 100.0 100.0 200.0 
1{5} 25.0 50.0 50.0 100.0 50.0 100.0 
2{1} 100.0 200.0 50.0 100.0 50.0 100.0 
2{2} 100.0 200.0 100.0 200.0 50.0 100.0 
2{3} 50.0 100.0 25.0 50.0 25.0 50.0 
2{4} 50.0 100.0 50.0 200.0 25.0 50.0 
2{5} 100.0 200.0 50.0 100.0 25.0 50.0 
3{1} 50.0 100.0 50.0 100.0 50.0 100.0 
3{2} 50.0 100.0 100.0 200.0 50.0 100.0 
3{3} 25.0 50.0 50.0 200.0 25.0 50.0 
3{4} 100.0 200.0 50.0 100.0 25.0 50.0 
3{5} 50.0 100.0 50.0 200.0 50.0 100.0 
4{1} 25.0 50.0 50.0 100.0 25.0 50.0 
4{2} 50.0 100.0 25.0 50.0 25.0 50.0 
4{3} 25.0 50.0 25.0 50.0 25.0 50.0 
4{4} 25.0 100.0 12.5 25.0 12.5 25.0 
4{5} 25.0 50.0 50.0 100.0 50.0 100.0 
3{1} 100.0 200.0 100.0 200.0 50.0 100.0 
5{2} 100.0 200.0 100.0 200.0 100.0 200.0 
5{3} 100.0 200.0 50.0 100.0 25.0 50.0 
5{4} 50.0 100.0 50.0 100.0 25.0 50.0 
5{5} 50.0 200.0 25.0 50.0 50.0 100.0 
6{1} 100.0 200.0 50.0 100.0 100.0 200.0 
6{2} 50.0 100.0 100.0 200.0 50.0 100.0 
6{3} 50.0 100.0 50.0 100.0 25.0 50.0 
6{4} 50.0 100.0 50.0 100.0 50.0 100.0 
6{5} 25.0 100.0 25.0 50.0 12.5 25.0 
7{1} 50.0 200.0 25.0 50.0 25.0 50.0 
7{2} 25.0 50.0 50.0 100.0 50.0 200.0 
7{3} 100.0 200.0 25.0 50.0 25.0 50.0 
7{4} 25.0 50.0 12.5 50.0 25.0 50.0 
7{5} 12.5 50.0 25.0 50.0 12.5 25.0 
 




а]pyrazin-8(7H)-ones – the most active was compound 
1{2}. It showed antimicrobial activity for all reference test 
strains and was more active than control Nevigramon and 
Flutsonazolum.  The most sensitive strains for this 
substance were S.aureus, Pr.vulgaris, C.albicans. 
Compound 2{4} has attracted our attention 




Sensitive to it were E.coli, P.aeruginosa, C.albicans. 
Generally, this group showed low antimicrobial activity, 
especially to gram-negative bacteria. 
The third group of these substances showed 
moderate antimicrobial and antifungal activity. There is 3-
(4-chloro-phenyl)-7-(4-fluoro-phenyl)-[1,2,4]triazolo[4,3-
а]pyrazin-8(7H)-one 3{3}, which has the best indicators 
of activity of the group.  




ones - showed the best antimicrobial and antifungal 
activity of all synthesized compounds. There is also 
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regularity of increasing activity, if the structure of 
molecules containing halogen atom. Compound 4{4} 
showed high values of antimicrobial activity against 
gram-negative microorganisms (МBstК – 12.5-25.0 
mkg/ml, МBcК – 25.0-50.0 mkg/ml) and was the most 
promising for further development. 




sufficiently high results of antimicrobial activity 
concerning to E. coli (МBstК – 25.0-50.0 mkg/ml, МBcК 
– 50.0-100.0 mkg/ml). The most active was compound 
5{3}, which was more active than control strains to 
S.aureus and C.albicans. 
Alkylated derivatives of [1,2,4]triazolo[4,3-
а]pyrazines showed concerning  high rates of activity. 
The substances which deserve attention are compounds 
that contain an acetamide fragment as in position number 
2 (compound 6{5}), and in position number 3 of 
heterocycle (compounds 7{4} і 7{5}). They have shown 
highest values among all of the studied compounds, 
which correlates well with the literature data [7, 12]. 
 
Experimental 
The weight of the substance (5 mg) was 
dissolved in 5 ml of dimethylformamide (DMF). The 2 ml 
of nutrient medium was poured in every of 10 sterile 
tubes. Then in the each tubes of the first row we brought 
to 2 ml of the substance, carefully mixed and than 2 ml 
was transferred to the next tube. The process was 
performed in sterile conditions with the full range of 
tubes. From the last tube 2 ml of the fluid was poured. In 
each row one tube with 2 ml of nutrient medium was left 
as a control. In this way we have received serial dilutions 
of the test substances in a liquid medium in 
concentrations ranging from 400 to 0.02 mg/ml. Next to 
the test tubes brought culture in an amount of 2·10
5
 
CFU/ml and incubated them for 18-24 h and temperature 
(37±0.5)°С. Microbial load for Candida albicans is 5·10
5
 




Design of molecular structure as the results of 
virtual screening is a convenient and effective tool to 
intensify the search for antimicrobial agents based on the 
new base structures. During the screening research we 
identified series of [1,2,4]triazolo[4,3-a]pyrazine-8-one 
derivatives with antimicrobial and antifungal activity. 
In the experiments was confirmed the presence 
of these types of activities for all of the synthesized 
compounds. The most pronounced effect showed 
compounds that contains in their structure aryl moiety 
with halogen atom, or N-arylatsetamide group in position 
3 or 2 of the heterocycle. Principal condition for the 
demonstration of antifungal activity is presence of Sulfur 
atom in the triazole cycle. 
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ANTIMICROBIAL ACTIVITY OF 
[1,2,4]TRIAZOLO[4,3-а]PYRAZIN-8(7H)-ONE 
DERIVATIVES 
Kulikovska K. Yu., Kovalenko S. S., Drushlyak O. G., 
Zhuravel I. O., Kovalenko S. M. 
kulikovskaja.k@gmail.com 
Today the problem of microbial resistance to antibacterial 
agents becomes the global one. Antimicrobial drugs that 
are in the pharmaceutical market do not satisfy the needs 
of modern treatment regimens, particularly Hospital-
acquired infections. Therefore, the search for new and 
effective means of this pharmacological group is an 
important task of medical chemistry.  From the literature 
it is known that derivatives of [1,2,4]triazolo[4,3-
a]pyrazine show a wide range of biological actions, 
including antimicrobial and fungicidal. This makes it 
relevant microbiological study of primary derivatives of 
[1,2,4]triazolo[4,3-a]pyrazine for identifying promising 
compounds of the series and then study it in biological 
experiment.Using the PASS C&T (Prediction Activity 
Spectra for Substances: Complex & Training) program 
and based on published data, we have generated virtual 
library of derivatives of [1,2,4]triazolo[4,3-a]pyrazine. As 
a result, we have received 35 new synthetic compounds of 
7 series that were not previously described in the 
literature. 
Materials and methods 
The research of antimicrobial and fungicidal activity of 
the synthesized compounds was carried out in the 
laboratory of antimicrobial agents GA "Mechnikov 
Institute of microbiology and immunology" under the 
leadership of  PhD, senior scientist V.V.Kazmirchuka. 
The activity of the synthesized compounds were studied 
by conventional method of the two-fold serial dilutions in 
liquid and solid nutrient medium. For primary screening 
we have used a set of clinical and reference strains of 
microorganism: Escherichia coli ATCC 25922 (F-50), 
Staphylococcus aureus ATCC 25923 (F-49), Bacillus 
anthracoides ATCC 1312, Pseudomonas aeruginosa 
ATCC 27853, Candida albicans ATCC 885-653. As the 
reference preparations were chosen Palin - modern 
antimicrobial agent of class of fluoroquinolones, 
Nevigramon - nalidixic acid derivative and Fluconazole - 
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modern antifungal agent. Activity of substances 
determined by the minimum bacteriostatic (MBstK) and 
minimal bactericidal (MBcK) concentrations. All 
experiments were accompanied by appropriate controls. 
Results and Discussion 
As a result of microbiological screening of  35 
compounds we have allowed to identify a number of 
derivatives of [1,2,4]triazolo[4,3-a]pyrazine-8(7H)-one 
with antimicrobial and antifungal activity. The most 
pronounced effect showed compounds that contains in 
their structure aryl moiety with halogen atom, or N-
arylatsetamide group in position 3 or 2 of the heterocycle. 
Principal condition for the demonstration of antifungal 
activity is presence of Sulfur atom in the triazole cycle. 
Conclusions 
The substance of the series N
7
-aryl/benzyl-3-thioxo-
[1,2,4]triazolo[4,3-а]pyrazin-8(7H)-ones showed the best 
antimicrobial and antifungal activity of all synthesized 
compounds. Compound 7-(3-chloro-2-methyl-phenyl)-3-
thioxo-[1,2,4]triazolo[4,3-а]pyrazin-8(7Н)-one 4{4} 
showed high values of antimicrobial activity against 
gram-negative microorganisms (МBstК – 12.5-25.0 
mkg/ml, МBcК – 25.0-50.0 mkg/ml) and was the most 
promising for further development. 
Key words: [1,2,4]triazolo[4,3-a]pyrazin-8(7H)-one 
derivatives, antimicrobial activity, antifungal activity. 
 
 
